Senedd members call on the UK Government to hasten compensation for those affected by the infected blood scandal, with rising ...

The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting ...

Fitusiran is a small interference RNA therapeutic designed to prevent bleeds in patients with hemophilia A or B by lowering antithrombin.

Having more choices about the treatment of hemophilia is empowering, but it also comes with challenges, columnist Jennifer Lynne writes.

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Senedd members urged the UK Government to speed up compensation payments to people infected and affected by the contaminated blood scandal. Labour’s Julie Morgan, who has campaigned on the issue for ...

Columnist Joe MacDonald explains how holding on to rituals has gotten his family through some challenging times with chronic illness.

The agreement with the GKV-Spitzenverband – the national association of statutory health insurance funds – means that Hemgenix (etranacogene dezaparvovec) can now be reimbursed across Germany's health ...

CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have successfully concluded negotiations on the reimbursement price of HEMGENIX®. This agreement marks ...

The U.S. Food and Drug Administration has approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the ...

A woman with a severe needle phobia has described how she discharged herself from hospital – despite needing treatment to prevent her ...